Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000116865 | SCV000202597 | benign | not specified | 2015-08-24 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001000210 | SCV001156718 | benign | Maple syrup urine disease | 2022-10-25 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001000210 | SCV001733022 | benign | Maple syrup urine disease | 2022-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001000210 | SCV001876538 | benign | Maple syrup urine disease | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001675620 | SCV001895110 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29306928, 14517957, 26232051, 27884173, 9621512, 20981092) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000116865 | SCV002051448 | benign | not specified | 2021-12-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001000210 | SCV002799063 | likely benign | Maple syrup urine disease | 2021-07-19 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000116865 | SCV000150939 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Diagnostic Laboratory, |
RCV000116865 | SCV001743361 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000116865 | SCV001923217 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000116865 | SCV001931478 | benign | not specified | no assertion criteria provided | clinical testing |